Correlation between metabolite concentrations in the frontal lobes, determined using 1H-MRS, and IQ in children with

Andrzej Urbanik1, Teresa Jadczak-Szumiło2, Monika Ostrogórska1

  • 1Department of Radiology, Collegium Medicum, Jagiellonian University, Krakow, Poland.

Polish Journal of Radiology
|November 20, 2025
PubMed

Insights

Children with Foetal Alcohol Spectrum Disorder (FASD) have lower IQs, linked to frontal lobe metabolic changes like elevated lipid levels, compared to healthy peers. This study explored the brain metabolism and IQ relationship in children with FASD.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Radiology

Background:

  • Foetal Alcohol Spectrum Disorder (FASD) encompasses conditions arising from prenatal alcohol exposure.
  • Understanding the neurobiological underpinnings of cognitive deficits in FASD is crucial.

Purpose of the Study:

  • To investigate the relationship between frontal lobe brain metabolism and IQ in children diagnosed with FASD.
  • To compare metabolic profiles and cognitive function between children with FASD and a control group.

Main Methods:

  • 124 children (5-17 years) with diagnosed FASD (FAS, pFAS, ARND) were assessed.
  • Cognitive function was evaluated using the Wechsler Intelligence Scale for Children (WISC-R).
  • Frontal lobe brain metabolism was analyzed using proton magnetic resonance spectroscopy (¹H-MRS).

Main Results:

  • Children with FASD exhibited significantly lower IQ scores (mean 90.42) compared to controls (mean 121.26).
  • Elevated Lip/Cr levels were observed in the left frontal lobe of children with FASD.
  • A significant negative correlation was found between IQ and Lip/Cr concentrations in the right and bilateral frontal lobes.

Conclusions:

  • Children with FASD demonstrate significantly impaired cognitive function (lower IQ) compared to healthy controls.
  • Prenatal alcohol exposure appears to induce frontal lobe metabolic alterations, specifically increased lipid levels, associated with reduced IQ in FASD.
  • These findings highlight potential neuroimaging biomarkers for cognitive deficits in FASD.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children from...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...